Article Archive: Damien Conover, CFA

Title Collection Author Date
Blockbusters Differentiate Novartis Stock Strategist Damien Conover, CFA 09/05/14
J&J's Strong 2Q Led by Pharmaceuticals Commentary Damien Conover, CFA 07/15/14
Stock-Picking Increasingly Critical in Health Care Quarter-End Insights Damien Conover, CFA 06/28/14
Merck Pays a High Price for Idenix Market Update Damien Conover, CFA 06/09/14
High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat Stock Strategist Damien Conover, CFA 05/07/14
Pfizer-Astra Deal Will Get Done US Videos Damien Conover, CFA 04/28/14
Johnson & Johnson's Pharma Group Leading the Way US Videos Damien Conover, CFA 04/15/14
The Sector Is Fairly Valued, but These Stocks Are Not US Videos Damien Conover, CFA 04/10/14
Makings of a Wide Moat in Diabetes Care Quarter-End Insights Damien Conover, CFA 03/28/14
AbbVie's Outlook Highly Dependent on Well-Positioned Humira Stock Strategist Damien Conover, CFA 12/14/12
Scale and Patent Protection Integral Parts of Lilly's Moat US Videos Damien Conover, CFA 12/03/12
Our Strong Long-Term Outlook for J&J Intact Market Update Damien Conover, CFA 10/16/12
Large Opportunity for Big Pharma Stock Strategist Industry Reports Damien Conover, CFA 08/06/12
Pfizer Still Looks Undervalued Market Update Damien Conover, CFA 07/31/12
J&J's Long-Term Outlook Remains Favorable Market Update Damien Conover, CFA 07/17/12
Sanofi Posts Slightly Disappointing 4Q Market Update Damien Conover, CFA 02/08/12
Glaxo Turning the Corner to Steady Long-Term Growth Market Update Damien Conover, CFA 02/07/12
Pfizer Posts In-Line 4Q as Generic Lipitor Weighs Market Update Damien Conover, CFA 01/31/12
Abbott Breakup Will Create Two Moaty Companies Stock Strategist Industry Reports Damien Conover, CFA 11/25/11
Strong New Drug Launches Offset Generic Competition in J&J's 3Q Market Update Damien Conover, CFA 10/18/11
New Drug Launches Help Offset Weakness in the Consumer Group at Johnson & Johnson Market Update Damien Conover, CFA 07/19/11
Strength Emerging in the Health-Care Sector Quarter-End Insights Damien Conover, CFA 07/01/11
Pfizer Holds Up in Face of Patent Losses Market Update Damien Conover, CFA 05/03/11
J&J Posts Strong 1Q, Boosted by Solid Drug Sales and Low Tax Rate Stock Strategist Damien Conover, CFA 04/19/11
The Next Wave of Blockbuster Diabetes Drugs Stock Strategist Industry Reports Damien Conover, CFA 09/10/10
Trends So Far in Big Pharma's Fourth Quarter Stock Strategist Industry Reports Damien Conover, CFA 02/01/10
The 2010 Outlook for Big Pharma Stocks Stock Strategist Industry Reports Damien Conover, CFA 01/21/10
Which Pharma Pipelines Rank Best? Stock Strategist Industry Reports Damien Conover, CFA 09/17/09
Which Pharma Pipelines Rank Best? Stock Strategist Damien Conover, CFA 09/17/09
Four Possibilities for Pharma Firms' Fair Values Stock Strategist Industry Reports Damien Conover, CFA 08/31/09
Four Possibilities for Pharma Firms' Fair Values Stock Strategist Damien Conover, CFA 08/18/09
Is Personalized Medicine a Good Pill for Pharma Firms? US Videos Damien Conover, CFA 06/17/09
Will Pharma Firms Get a Shot from Swine Flu? US Videos Damien Conover, CFA 04/27/09
Improved Outlook for Big Pharma Stocks in 2009 Stock Strategist Industry Reports Damien Conover, CFA 01/08/09
A Health-Care Pick Equipped for Outperformance US Videos Damien Conover, CFA 06/17/08